- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Market Overview
The Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Gene Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Gene Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gene Therapy market has been segmented into:
Ex vivo
In Vivo
By Application, Gene Therapy has been segmented into:
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Gene Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Gene Therapy Market Share Analysis
Gene Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gene Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Gene Therapy are:
Bluebird Bio
Advantagene
Dimension Therapeutics
Sangamo
Vical Inc.
Spark Therapeutics
Celladon
Avalanche Bio
Among other players domestic and global, Gene Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Gene Therapy Market Overview
1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Type
1.2.1 Global Gene Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Gene Therapy Revenue Market Share by Type in 2019
1.2.3 Ex vivo
1.2.4 In Vivo
1.3 Global Gene Therapy Market by Application
1.3.1 Overview: Global Gene Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious disease
1.3.5 Cardiovascular disease
1.3.6 Other
1.4 Global Gene Therapy Market by Regions
1.4.1 Global Gene Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Gene Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Gene Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Gene Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bluebird Bio
2.1.1 Bluebird Bio Details
2.1.2 Bluebird Bio Major Business
2.1.3 Bluebird Bio SWOT Analysis
2.1.4 Bluebird Bio Product and Services
2.1.5 Bluebird Bio Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Advantagene
2.2.1 Advantagene Details
2.2.2 Advantagene Major Business
2.2.3 Advantagene SWOT Analysis
2.2.4 Advantagene Product and Services
2.2.5 Advantagene Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dimension Therapeutics
2.3.1 Dimension Therapeutics Details
2.3.2 Dimension Therapeutics Major Business
2.3.3 Dimension Therapeutics SWOT Analysis
2.3.4 Dimension Therapeutics Product and Services
2.3.5 Dimension Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sangamo
2.4.1 Sangamo Details
2.4.2 Sangamo Major Business
2.4.3 Sangamo SWOT Analysis
2.4.4 Sangamo Product and Services
2.4.5 Sangamo Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Vical Inc.
2.5.1 Vical Inc. Details
2.5.2 Vical Inc. Major Business
2.5.3 Vical Inc. SWOT Analysis
2.5.4 Vical Inc. Product and Services
2.5.5 Vical Inc. Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Spark Therapeutics
2.6.1 Spark Therapeutics Details
2.6.2 Spark Therapeutics Major Business
2.6.3 Spark Therapeutics Product and Services
2.6.4 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celladon
2.7.1 Celladon Details
2.7.2 Celladon Major Business
2.7.3 Celladon Product and Services
2.7.4 Celladon Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Avalanche Bio
2.8.1 Avalanche Bio Details
2.8.2 Avalanche Bio Major Business
2.8.3 Avalanche Bio Product and Services
2.8.4 Avalanche Bio Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gene Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Therapy Players Market Share
3.2.2 Top 10 Gene Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Gene Therapy Revenue and Market Share by Regions
4.2 North America Gene Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Gene Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Gene Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Gene Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Gene Therapy Revenue and Growth Rate (2015-2020)
5 North America Gene Therapy Revenue by Countries
5.1 North America Gene Therapy Revenue by Countries (2015-2020)
5.2 USA Gene Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Gene Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Gene Therapy Revenue and Growth Rate (2015-2020)
6 Europe Gene Therapy Revenue by Countries
6.1 Europe Gene Therapy Revenue by Countries (2015-2020)
6.2 Germany Gene Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Gene Therapy Revenue and Growth Rate (2015-2020)
6.4 France Gene Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Gene Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Gene Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gene Therapy Revenue by Countries
7.1 Asia-Pacific Gene Therapy Revenue by Countries (2015-2020)
7.2 China Gene Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Gene Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Gene Therapy Revenue and Growth Rate (2015-2020)
7.5 India Gene Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Gene Therapy Revenue and Growth Rate (2015-2020)
8 South America Gene Therapy Revenue by Countries
8.1 South America Gene Therapy Revenue by Countries (2015-2020)
8.2 Brazil Gene Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Gene Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Gene Therapy by Countries
9.1 Middle East & Africa Gene Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Gene Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Gene Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Gene Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Gene Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Gene Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Gene Therapy Market Forecast by Type (2019-2024)
10.3 Ex vivo Revenue Growth Rate (2015-2025)
10.4 In Vivo Revenue Growth Rate (2015-2025)
11 Global Gene Therapy Market Segment by Application
11.1 Global Gene Therapy Revenue Market Share by Application (2015-2020)
11.2 Gene Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Monogenic Revenue Growth (2015-2020)
11.5 Infectious disease Revenue Growth (2015-2020)
11.6 Cardiovascular disease Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Gene Therapy Market Size Forecast (2021-2025)
12.1 Global Gene Therapy Market Size Forecast (2021-2025)
12.2 Global Gene Therapy Market Forecast by Regions (2021-2025)
12.3 North America Gene Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Gene Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Gene Therapy Revenue Market Forecast (2021-2025)
12.6 South America Gene Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Gene Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Gene Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gene Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Gene Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Gene Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bluebird Bio Corporate Information, Location and Competitors
Table 7. Bluebird Bio Gene Therapy Major Business
Table 8. Bluebird Bio Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Bluebird Bio SWOT Analysis
Table 10. Bluebird Bio Gene Therapy Product and Solutions
Table 11. Bluebird Bio Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Advantagene Corporate Information, Location and Competitors
Table 13. Advantagene Gene Therapy Major Business
Table 14. Advantagene Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Advantagene SWOT Analysis
Table 16. Advantagene Gene Therapy Product and Solutions
Table 17. Advantagene Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Dimension Therapeutics Corporate Information, Location and Competitors
Table 19. Dimension Therapeutics Gene Therapy Major Business
Table 20. Dimension Therapeutics Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Dimension Therapeutics SWOT Analysis
Table 22. Dimension Therapeutics Gene Therapy Product and Solutions
Table 23. Dimension Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Sangamo Corporate Information, Location and Competitors
Table 25. Sangamo Gene Therapy Major Business
Table 26. Sangamo Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Sangamo SWOT Analysis
Table 28. Sangamo Gene Therapy Product and Solutions
Table 29. Sangamo Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Vical Inc. Corporate Information, Location and Competitors
Table 31. Vical Inc. Gene Therapy Major Business
Table 32. Vical Inc. Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Vical Inc. SWOT Analysis
Table 34. Vical Inc. Gene Therapy Product and Solutions
Table 35. Vical Inc. Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Spark Therapeutics Corporate Information, Location and Competitors
Table 37. Spark Therapeutics Gene Therapy Major Business
Table 38. Spark Therapeutics Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Spark Therapeutics SWOT Analysis
Table 40. Spark Therapeutics Gene Therapy Product and Solutions
Table 41. Spark Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Celladon Corporate Information, Location and Competitors
Table 43. Celladon Gene Therapy Major Business
Table 44. Celladon Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Celladon SWOT Analysis
Table 46. Celladon Gene Therapy Product and Solutions
Table 47. Celladon Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Avalanche Bio Corporate Information, Location and Competitors
Table 49. Avalanche Bio Gene Therapy Major Business
Table 50. Avalanche Bio Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Avalanche Bio SWOT Analysis
Table 52. Avalanche Bio Gene Therapy Product and Solutions
Table 53. Avalanche Bio Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Gene Therapy Revenue (Million USD) by Players (2015-2020)
Table 55. Global Gene Therapy Revenue Share by Players (2015-2020)
Table 56. Global Gene Therapy Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Gene Therapy Revenue Market Share by Regions (2015-2020)
Table 58. North America Gene Therapy Revenue by Countries (2015-2020)
Table 59. North America Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 60. Europe Gene Therapy Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Gene Therapy Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Gene Therapy Revenue by Countries (2015-2020)
Table 63. South America Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Gene Therapy Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 66. Global Gene Therapy Revenue (Million USD) by Type (2015-2020)
Table 67. Global Gene Therapy Revenue Share by Type (2015-2020)
Table 68. Global Gene Therapy Revenue Forecast by Type (2021-2025)
Table 69. Global Gene Therapy Revenue by Application (2015-2020)
Table 70. Global Gene Therapy Revenue Share by Application (2015-2020)
Table 71. Global Gene Therapy Revenue Forecast by Application (2021-2025)
Table 72. Global Gene Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Gene Therapy Picture
Figure 2. Global Gene Therapy Revenue Market Share by Type in 2019
Figure 3. Ex vivo Picture
Figure 4. In Vivo Picture
Figure 5. Gene Therapy Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Monogenic Picture
Figure 8. Infectious disease Picture
Figure 9. Cardiovascular disease Picture
Figure 10. Other Picture
Figure 11. Global Gene Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Gene Therapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Gene Therapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Gene Therapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Gene Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Gene Therapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Gene Therapy Revenue Market Share by Regions in 2018
Figure 25. North America Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Gene Therapy Revenue Market Share by Countries in 2019
Figure 32. USA Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Gene Therapy Revenue Market Share by Countries in 2019
Figure 37. Germany Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 39. France Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Gene Therapy Revenue Market Share by Countries in 2019
Figure 44. China Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 47. India Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Gene Therapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Gene Therapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Gene Therapy Revenue Share by Type (2015-2020)
Figure 60. Global Gene Therapy Revenue Share by Type in 2019
Figure 61. Global Gene Therapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Ex vivo Revenue Growth Rate (2015-2020)
Figure 63. Global In Vivo Revenue Growth Rate (2015-2020)
Figure 64. Global Gene Therapy Revenue Share by Application (2015-2020)
Figure 65. Global Gene Therapy Revenue Share by Application in 2019
Figure 66. Global Gene Therapy Market Share Forecast by Application (2021-2025)
Figure 67. Global Cancer Revenue Growth Rate (2015-2020)
Figure 68. Global Monogenic Revenue Growth Rate (2015-2020)
Figure 69. Global Infectious disease Revenue Growth Rate (2015-2020)
Figure 70. Global Cardiovascular disease Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Gene Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Gene Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Gene Therapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Gene Therapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Gene Therapy Revenue Market Forecast (2021-2025)
Figure 78. South America Gene Therapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Gene Therapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
